US 10034863
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
granted A61KA61K31/4245A61K9/0053
Quick answer
US patent 10034863 (Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease) held by PTC THERAPEUTICS, INC. expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4245, A61K9/0053, A61K9/145, A61P